Peggy Siegal, the once omnipresent New York publicist, is describing her first conversation with Jeffrey Epstein. It was a ...

Discover the behind-the-scenes story of KPop Demon Hunters, the groundbreaking animated film that took Netflix by storm, in this exclusive interview.

Regeneron Pharmaceuticals, Inc. ( REGN) TD Cowen 46th Annual Health Care Conference March 4, 2026 9:10 AM EST Good morning, everyone. Tyler Van Buren here, senior biotech analyst at TD Cowen. Thank ...

Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...

Researchers at the company are trying to understand their A.I. system’s mind—examining its neurons, running it through psychology experiments, and putting it on the therapy couch.

Do you stare at a math word problem and feel completely stuck? You're not alone. These problems mix reading comprehension with complex math concepts, making them a common hurdle for students. The good ...

Lucas is a writer and narrative designer from Argentina with over 15 years of experience writing for games and news. He keeps a watchful eye at the gaming world and loves to write about the hottest ...

When my cofounder and I were accepted into a competitive startup accelerator program in fall 2025, we applied with an ambitious idea: to build an “AI scientist” for machine learning research. What ...

Looking for help with today's NYT Strands puzzle? Here's an extra hint to help you uncover the right words, as well as all of today's answers and Spangram.

The TV personality, 38, joined the posh cast of the E4 reality series as an extra before being promoted to the main cast, but Ashley has revealed she was paid just £50 per filming session and had to ...

Apple released iOS 26.2.1 for the public last week, but if you haven't updated yet, you may want to hold off. A number of users are reporting that the latest iOS build is causing some serious issues.

Thank you, Jason. After that, we'll provide updates on the significant progress we've made with lonvo-z, which is being developed as a potential one-time treatment for patients with hereditary ...